| Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma P Chuntova, A Yamamichi, T Chen, R Narayanaswamy, S Ronseaux, ... Journal for ImmunoTherapy of Cancer 10 (5), 2022 | 15 | 2022 |
| Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice P Chuntova, Y Hou, R Naka, A Yamamichi, T Chen, Y Goretsky, R Hatae, ... Neuro-Oncology, 2021 | 7 | 2021 |
| Glioma-neuronal circuit remodeling induces regional immunosuppression T Nejo, S Krishna, C Jimenez, A Yamamichi, JS Young, ... bioRxiv, 2023.08. 04.548295, 2023 | 2 | 2023 |
| Enhanced learning and sensory salience in a cerebellar mouse autism model M Oostland, M Kislin, Y Chen, T Chen, SJ Venditto, B Deverett, ... bioRxiv, 2021.12. 23.474034, 2021 | 2* | 2021 |
| Enhancing CAR-T Cell Metabolism to Overcome Hypoxic Conditions in the Brain Tumor Microenvironment R Hatae, K Kyewalabye, A Yamamichi, T Chen, P Su, P Chuntova, T Nejo, ... bioRxiv, 2023 | 1 | 2023 |
| Glioma-induced neuronal remodeling promotes regional immunosuppression T Nejo, S Krishna, C Jimenez, A Yamamichi, JS Young, T Chen, ... Cancer Research 83 (7_Supplement), 2497-2497, 2023 | 1 | 2023 |
| EXTH-18. DEVELOPMENT OF A TRANSGENIC MOUSE MODEL ENABLING COMPARATIVE ANALYSIS OF CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING IMMUNE CELL POPULATIONS FOR CANCER IMMUNOTHERAPY R Hatae, P Watchmaker, A Yamamichi, K Kyewalabye, K Okada, S Phyu, ... Neuro-Oncology 25 (Supplement_5), v227-v227, 2023 | | 2023 |
| IMMU-04. LOW-INTENSITY PULSED ULTRASOUND ENHANCES CAR T CELL THERAPY BY INDUCING TWO-WAY IMMUNE CELL TRAFFICKING–T CELL INTO TUMOR AND MYELOID CELL INTO PERIPHERY IN A … A Yamamichi, T Chen, S Phyu, J Young, K Kyewarabye, R Hatae, ... Neuro-Oncology 25 (Supplement_5), v141-v142, 2023 | | 2023 |
| 277 SynNotch-CAR T cells demonstrate potent anti-tumor efficacy in a preclinical immunocompetent mouse model for glioblastoma S Lakshmanachetty, M Simic, P Watchmaker, A Yamamichi, T Chen, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 843 Intra-cerebral spinal fluid vaccination to facilitate antigen-specific T-cell responses in the CNS tumors A Yamamichi, S Phyu, T Chen, A Kazuyoshi, N Harada, H Okada Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Pre-treatment of CAR-T cells with met+ rap improves the mitochondrial function and anti-tumor efficacy in a hypoxic glioma microenvironment R Hatae, K Kyewalabye, A Yamamichi, T Chen, S Phyu, P Chuntova, ... Cancer Research 83 (7_Supplement), 1774-1774, 2023 | | 2023 |
| Melanocyte PDL1 promotes early tumor progression in a novel autochthonous NRAS- mutant melanoma model CO Ontiveros, T Chen, C Murray, A Kornepati, Y Deng, P Blinkiewicz, ... American Association of Immunologists, 2023 | | 2023 |
| CNSC-19. GLIOMA-INDUCED NEURONAL REMODELING PROMOTES REGIONAL IMMUNOSUPPRESSION T Nejo, S Krishna, JS Young, A Yamamichi, C Jimenez, T Chen, ... Neuro-Oncology 24 (Supplement_7), vii26-vii26, 2022 | | 2022 |
| IMMU-08. NOVEL NANOPARTICLE-BASED DELIVERY OF H3. 3K27M PEPTIDE TO TUMOR-ASSOCIATED MACROPHAGES ENHANCES THE TUMOR HOMING OF H3. 3K27M-TCR TRANSDUCED T-CELLS IN HLA-A2/DR1 … A Yamamichi, P Chuntova, B Kakihara, T Chen, D Diebold, N Harada, ... Neuro-Oncology 23 (Supplement_6), vi93-vi93, 2021 | | 2021 |
